Ryan & Maniskas, LLP Announces Investigation of ISTA Pharmaceuticals, Inc.

WAYNE, Pa.--(BUSINESS WIRE)--Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/ista) is investigating potential claims against the board of directors of ISTA Pharmaceuticals, Inc. (“ISTA” or the "Company") (NASDAQ: ISTA) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s efforts to sell ISTA to Bausch & Lomb in a transaction valued at approximately $500 million.